Baudax Bioinc Stock Performance
| BXRX Stock | USD 0.01 0.0009 7.83% |
The firm shows a Beta (market volatility) of -4.33, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Baudax BioInc are expected to decrease by larger amounts. On the other hand, during market turmoil, Baudax BioInc is expected to outperform it. Baudax BioInc has an expected return of -0.78%. Please make sure to confirm Baudax BioInc treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Baudax BioInc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Baudax BioInc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in May 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Last Split Factor 1:40 | Last Split Date 2022-12-01 |
1 | Insider Trading | 03/11/2024 |
2 | Disposition of tradable shares by Kim Yong Chan of Baudax BioInc subject to Rule 16b-3 | 04/05/2024 |
| Begin Period Cash Flow | 5.6 M |
Baudax |
Baudax BioInc Relative Risk vs. Return Landscape
If you would invest 2.74 in Baudax BioInc on January 19, 2024 and sell it today you would lose (1.68) from holding Baudax BioInc or give up 61.31% of portfolio value over 90 days. Baudax BioInc is currently does not generate positive expected returns and assumes 12.5645% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Baudax, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Baudax BioInc Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Baudax BioInc's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Baudax BioInc, and traders can use it to determine the average amount a Baudax BioInc's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0623
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BXRX |
Estimated Market Risk
| 12.56 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.78 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Baudax BioInc is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Baudax BioInc by adding Baudax BioInc to a well-diversified portfolio.
Baudax BioInc Fundamentals Growth
Baudax Stock prices reflect investors' perceptions of the future prospects and financial health of Baudax BioInc, and Baudax BioInc fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Baudax Stock performance.
| Return On Equity | -47.04 | ||||
| Return On Asset | -1.15 | ||||
| Operating Margin | (27.60) % | ||||
| Current Valuation | 17.72 M | ||||
| Shares Outstanding | 43.59 M | ||||
| Price To Earning | 0.03 X | ||||
| Price To Book | 0.68 X | ||||
| Price To Sales | 0.75 X | ||||
| Revenue | 1.27 M | ||||
| Gross Profit | (5.74 M) | ||||
| EBITDA | (34.76 M) | ||||
| Net Income | (7.15 M) | ||||
| Cash And Equivalents | 5.65 M | ||||
| Cash Per Share | 0.28 X | ||||
| Total Debt | 7.12 M | ||||
| Debt To Equity | 2.26 % | ||||
| Current Ratio | 0.53 X | ||||
| Book Value Per Share | (0.84) X | ||||
| Cash Flow From Operations | (14.31 M) | ||||
| Earnings Per Share | (94.13) X | ||||
| Market Capitalization | 950.33 K | ||||
| Total Asset | 10.03 M | ||||
| Retained Earnings | (190.9 M) | ||||
| Working Capital | (15.11 M) | ||||
| Current Asset | 21.72 M | ||||
| Current Liabilities | 7.92 M | ||||
About Baudax BioInc Performance
To evaluate Baudax BioInc Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Baudax BioInc generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Baudax Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Baudax BioInc market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Baudax's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 672.05 | 549.72 | |
| Return On Tangible Assets | (6.69) | (7.03) | |
| Return On Capital Employed | 4.47 | 4.70 | |
| Return On Assets | (6.74) | (6.40) | |
| Return On Equity | 2.18 | 1.22 |
Things to note about Baudax BioInc performance evaluation
Checking the ongoing alerts about Baudax BioInc for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Baudax BioInc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Baudax BioInc generated a negative expected return over the last 90 days | |
| Baudax BioInc has high historical volatility and very poor performance | |
| Baudax BioInc has some characteristics of a very speculative penny stock | |
| Baudax BioInc has a very high chance of going through financial distress in the upcoming years | |
| The company currently holds 7.12 M in liabilities with Debt to Equity (D/E) ratio of 2.26, implying the company greatly relies on financing operations through barrowing. Baudax BioInc has a current ratio of 0.52, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Baudax BioInc until it has trouble settling it off, either with new capital or with free cash flow. So, Baudax BioInc's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Baudax BioInc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Baudax to invest in growth at high rates of return. When we think about Baudax BioInc's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 1.27 M. Net Loss for the year was (7.15 M) with loss before overhead, payroll, taxes, and interest of (5.74 M). | |
| Baudax BioInc currently holds about 5.65 M in cash with (14.31 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Baudax BioInc has a poor financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Disposition of tradable shares by Kim Yong Chan of Baudax BioInc subject to Rule 16b-3 |
- Analyzing Baudax BioInc's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Baudax BioInc's stock is overvalued or undervalued compared to its peers.
- Examining Baudax BioInc's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Baudax BioInc's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Baudax BioInc's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Baudax BioInc's stock. These opinions can provide insight into Baudax BioInc's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Baudax BioInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Baudax Stock please use our How to Invest in Baudax BioInc guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Baudax Stock analysis
When running Baudax BioInc's price analysis, check to measure Baudax BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Baudax BioInc is operating at the current time. Most of Baudax BioInc's value examination focuses on studying past and present price action to predict the probability of Baudax BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Baudax BioInc's price. Additionally, you may evaluate how the addition of Baudax BioInc to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is Baudax BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Baudax BioInc. If investors know Baudax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Baudax BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (94.13) | Revenue Per Share 0.318 | Quarterly Revenue Growth (0.23) | Return On Assets (1.15) | Return On Equity (47.04) |
The market value of Baudax BioInc is measured differently than its book value, which is the value of Baudax that is recorded on the company's balance sheet. Investors also form their own opinion of Baudax BioInc's value that differs from its market value or its book value, called intrinsic value, which is Baudax BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Baudax BioInc's market value can be influenced by many factors that don't directly affect Baudax BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Baudax BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Baudax BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Baudax BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.